ubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution [Liq-10]

RxCUI
1088930
RxNorm name
ubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution [Liq-10]
Term type
SBD
Status
Active
Updated
2026-07-15 00:15:30

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032011
Active start
032011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
vitamin E0.2 UNT / 1 MLvitamin Evitamin E
ubidecarenone20 MG / 1 MLubidecarenoneubidecarenone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
vitamin E11256
ubidecarenone21406

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
54023929307rxnav_historical

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01EBOther cardiac preparationsATC1-4ubidecarenone
ATCA11HAOther plain vitamin preparationsATC1-4vitamin E
MEDRTD014451UbiquinoneCHEMhas_ingredientubidecarenone
MEDRTD014810Vitamin ECHEMhas_ingredientvitamin E
MEDRTD000544Alzheimer DiseaseDISEASEmay_preventvitamin E
MEDRTD000544Alzheimer DiseaseDISEASEmay_treatvitamin E
MEDRTD000743Anemia, HemolyticDISEASEmay_preventvitamin E
MEDRTD000743Anemia, HemolyticDISEASEmay_treatvitamin E
MEDRTD000787Angina PectorisDISEASEmay_treatubidecarenone
MEDRTD001997Bronchopulmonary DysplasiaDISEASEmay_preventvitamin E
MEDRTD004342Drug HypersensitivityDISEASEci_withvitamin E
MEDRTD004342Drug HypersensitivityDISEASEci_withubidecarenone
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventubidecarenone
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_preventvitamin E
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_treatvitamin E
MEDRTD015673Fatigue Syndrome, ChronicDISEASEmay_treatubidecarenone
MEDRTD006333Heart FailureDISEASEmay_treatubidecarenone
MEDRTD006816Huntington DiseaseDISEASEmay_treatubidecarenone
MEDRTD006949HyperlipidemiasDISEASEmay_treatubidecarenone
MEDRTD006973HypertensionDISEASEmay_treatubidecarenone
MEDRTD014811Vitamin E DeficiencyDISEASEmay_treatvitamin E
MEDRTD014811Vitamin E DeficiencyDISEASEmay_preventvitamin E
MEDRTN0000000163Enzyme InteractionsMOAhas_moaubidecarenone
MEDRTN0000000170Free Radical Scavenging ActivityMOAhas_moavitamin E
MEDRTN0000009934Decreased Vitamin Uptake and ModificationPEhas_pevitamin E
MEDRTN0000009925Unknown Physiological EffectPEhas_peubidecarenone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYSBD
CODESRxCUI1088930
NAMESRXNAV_STRLiq-10 (coenzyme Q10 20 MG/ML / vitamin E 0.2 UNT/ML) Oral Solution
NAMESRxNorm Nameubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution [Liq-10]
NAMESRxNorm SynonymLiq-10 (alpha-tocopherol 0.2 UNT/ML / ubidecarenone 20 MG//ML) Oral Solution
NAMESRxNorm SynonymLiq-10 (coenzyme Q10 20 MG/ML / vitamin E 0.2 UNT/ML) Oral Solution